These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


81 related items for PubMed ID: 1876049

  • 1. [D-Met2]-FMRFamide (DMFa): production of naloxone-sensitive antinociception in mouse tail-flick test.
    Raffa RB, Connelly CD.
    NIDA Res Monogr; 1990; 105():391-2. PubMed ID: 1876049
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Supraspinal antinociception produced by [D-Met2]-FMRFamide in mice.
    Raffa RB, Connelly CD.
    Neuropeptides; 1992 Jul; 22(3):195-203. PubMed ID: 1331846
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The actions of FMRF-NH2 and FMRF-NH2 related peptides on mammals.
    Raffa RB.
    NIDA Res Monogr; 1990 Jul; 105():243-9. PubMed ID: 1678861
    [Abstract] [Full Text] [Related]

  • 6. Effects of naloxone and D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 and the protein kinase inhibitors H7 and H8 on acute morphine dependence and antinociceptive tolerance in mice.
    Bilsky EJ, Bernstein RN, Wang Z, Sadée W, Porreca F.
    J Pharmacol Exp Ther; 1996 Apr; 277(1):484-90. PubMed ID: 8613958
    [Abstract] [Full Text] [Related]

  • 7. Antinociceptive action of intracerebroventricularly administered dynorphin and other opioid peptides in the rat.
    Tiseo PJ, Geller EB, Adler MW.
    J Pharmacol Exp Ther; 1988 Aug; 246(2):449-53. PubMed ID: 2900324
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Antinociceptive effects of intrathecally administered F8Famide and FMRFamide in the rat.
    Gouardères C, Sutak M, Zajac JM, Jhamandas K.
    Eur J Pharmacol; 1993 Jun 11; 237(1):73-81. PubMed ID: 8102975
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Mu receptor and Gi2alpha antisense attenuate [D-Met2]-FMRFamide antinociception in mice.
    Raffa RB, Stone DJ.
    Peptides; 1998 Jun 11; 19(7):1171-5. PubMed ID: 9786166
    [Abstract] [Full Text] [Related]

  • 12. An investigation of the antinociceptive activity of calcitonin gene-related peptide alone and in combination with morphine: correlation to 45Ca++ uptake by synaptosomes.
    Welch SP, Cooper CW, Dewey WL.
    J Pharmacol Exp Ther; 1988 Jan 11; 244(1):28-33. PubMed ID: 3257266
    [Abstract] [Full Text] [Related]

  • 13. Antinociceptive activity of salmon calcitonin injected intraventricularly in mice: modulation of morphine antinociception.
    Welch SP, Cooper CW, Dewey WL.
    J Pharmacol Exp Ther; 1986 Apr 11; 237(1):54-8. PubMed ID: 3958973
    [Abstract] [Full Text] [Related]

  • 14. In vivo pharmacological characterization of SoRI 9409, a nonpeptidic opioid mu-agonist/delta-antagonist that produces limited antinociceptive tolerance and attenuates morphine physical dependence.
    Wells JL, Bartlett JL, Ananthan S, Bilsky EJ.
    J Pharmacol Exp Ther; 2001 May 11; 297(2):597-605. PubMed ID: 11303048
    [Abstract] [Full Text] [Related]

  • 15. A-18-famide and F-8-famide, endogenous mammalian equivalents of the molluscan neuropeptide FMRFamide (Phe-Met-Arg-Phe-NH2), inhibit colonic bead expulsion time in mice.
    Raffa RB, Jacoby HI.
    Peptides; 1989 May 11; 10(4):873-5. PubMed ID: 2587427
    [Abstract] [Full Text] [Related]

  • 16. Comparative action of Phe-Leu-Phe-Gln-Pro-Gln-Arg-Phe-NH2 analogs on intestinal motility and nociception in rats.
    Million M, Fioramonti J, Gicquel S, Zajac JM, Bueno L.
    J Pharmacol Exp Ther; 1993 Apr 11; 265(1):96-102. PubMed ID: 8474035
    [Abstract] [Full Text] [Related]

  • 17. Dissociation of opioid antinociception and central gastrointestinal propulsion in the mouse: studies with naloxonazine.
    Heyman JS, Williams CL, Burks TF, Mosberg HI, Porreca F.
    J Pharmacol Exp Ther; 1988 Apr 11; 245(1):238-43. PubMed ID: 2834537
    [Abstract] [Full Text] [Related]

  • 18. A characterization of the antinociception produced by intracerebroventricular injection of 8-(N,N-diethylamino)octyl-3,4,5-trimethoxybenzoate in mice.
    Welch SP, Dewey WL.
    J Pharmacol Exp Ther; 1986 Nov 11; 239(2):320-6. PubMed ID: 3095536
    [Abstract] [Full Text] [Related]

  • 19. Relative involvement of mu, kappa and delta receptor mechanisms in opiate-mediated antinociception in mice.
    Ward SJ, Takemori AE.
    J Pharmacol Exp Ther; 1983 Mar 11; 224(3):525-30. PubMed ID: 6131119
    [Abstract] [Full Text] [Related]

  • 20. Neurotensin-induced antinociception in mice: antagonism by thyrotropin-releasing hormone.
    Osbahr AJ, Nemeroff CB, Luttinger D, Mason GA, Prange AJ.
    J Pharmacol Exp Ther; 1981 Jun 11; 217(3):645-51. PubMed ID: 6112261
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.